𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Sequential methotrexate and 5-fluorouracil in the treatment of non-small cell carcinoma of the lung

✍ Scribed by Wood, Christine D.; Slevin, Maurice L.; Ponder, Bruce A.; Wrigley, Peter F.M.

Book ID
121980051
Publisher
Elsevier Science
Year
1985
Weight
268 KB
Volume
21
Category
Article
ISSN
0277-5379

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Cisplatin, continuous-infusion 5-fluorou
Cisplatin, continuous-infusion 5-fluorouracil, and intermediate-dose methotrexate in the treatment of unresectable non-small cell carcinoma of the lung
✍ Catherine A. Wheeler; Lawrence N. Shulman; Steven E. Come; Lowell E. Schnipper; πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 377 KB πŸ‘ 2 views

Forty-one patients with unresectable non-small cell carcinoma of the lung (NSCCL) were treated with cisplatin 20 mg/m2/d for 5 days as a daily bolus injection, 5-fluorouracil 800 mg/m2/d by continuous infusion for 5 days, and intermediate-dose methotrexate 200 mg/m2 on days 15 and 22 of a 28-day cyc

Sequential methotrexate–5-fluorouracil t
Sequential methotrexate–5-fluorouracil treatment of squamous cell carcinoma of the head and neck
✍ Ulrik Ringborg; GΓ–Sta Ewert; Jan Kinnman; Per-Gotthard Lundqvist; Hans Strander πŸ“‚ Article πŸ“… 1983 πŸ› John Wiley and Sons 🌐 English βš– 271 KB πŸ‘ 2 views

Thirty-six patients with squamous cell carcinoma of the head and neck were treated with sequential methotrexate-5-fluorouracil followed by leucovorin rescue. The frequency of objective tumor regression obtained was 64% (complete response + partial response) with 19% complete regression. In 20 not pr